Biocept Inc (NASDAQ:BIOC) said it has appointed certified public accountant Quyen Dao-Haddock to its board of directors, bringing her more than 20 years of financial and accounting experience to the audit committee.
This increases board membership to eight for the San Diego-based provider of molecular diagnostic assays, products and services.
Biocept CEO Samuel D Riccitelli said Dao-Haddock’s extensive financial experience leading accounting and finance departments, and overseeing technical accounting, budgeting and forecasting, financial modelling, cash management and SEC reporting, make her a valuable addition.
READ: Biocept to use CNSide assay in study looking at biomarkers in patients with metastatic breast cancer
“We expect Quyen will make significant contributions as we seek standard-of-care status for our proprietary cerebrospinal fluid assay CNSide and focus on delivering value to our stockholders,” Riccitelli said in a statement.
Dao-Haddock serves as controller of IQHQ Inc, a US$2.5 billion start-up real estate investment trust focused on the life sciences industry, with responsibility for increasing the scale of the accounting and finance department and establishing and implementing comprehensive accounting policies.
“It’s an exciting time to join the Biocept board as the company directs its resources toward providing valuable information to improve clinical outcomes for patients with cancer and central nervous system involvement, who oftentimes have extremely poor prognoses,” said Dao-Haddock. “I’m delighted to utilize my skills and expertise to support the advancement of CNSide and the company’s diagnostic programs.”
She was previously the chief accounting officer of Presidio Property Trust, Inc., where she was responsible for all financial and accounting operations of this REIT with more than $30 million in annual revenues and $200 million in assets. She began her career as an audit manager at KPMG LLP, according to Biocept.
The company said Dao-Haddock also serves on the audit and compliance committee of Sharp HealthCare. She received a BS in Business Administration, Accounting from San Diego State University.
Contact the author at susie@proactiveinvestors.com